Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
Clinical approach to drug resistance interpretation: expert advice.
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Genetic and catalytic efficiency structure of an HCV protease quasispecies.
Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.
Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral load.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
New antiretroviral drugs and approaches to HIV treatment.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.